Table 1 Eligibility criteria
Inclusion criteria | |
|---|---|
1 | Age ≥ 18 years |
2 | Symptomatic osteoarthritis of hip or knee (following the revised criteria of the American College of Rheumatology) |
3 | Willingness to comply with follow-up assessments and treatment |
4 | Ability to understand, read and speak German |
Exclusion criteria | |
1 | Endoprothetic replacement of hip or knee joint |
2 | Inflammatory arthropathy of the hip or the knee |
3 | Acute, hot, red and swollen knee or hip joint (unknown focus) |
4 | Inflammatory system diseases which could interfere with the evaluation of the therapy procedure |
5 | CNS diseases, especially epilepsy |
6 | Anamnesis of deep vein thrombosis in the past 12 months |
7 | Severe lung disease such as e.g. COPD stages GOLD III – GOLD IV |
8 | Heart failure NYHA III – NYHA IV |
9 | Myocardial ischemia with or without intervention within the last 3 months before inpatient admission |
10 | Cancer in advanced stage |
11 | Large skin wounds or inflammatory and ulcerated dermatosis of the legs |
12 | Severe febrile infectious diseases Non treated hypertension |
13 | Participation in another clinical study within the past four weeks |
14 | Pregnancy |